| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
2-macroglobulin gene in AD
From the Department of Epidemiology & Biostatistics (Drs. Koster, Houwing–Duistermaat, Roks, Ott, Hofman, Breteler, and van Duijn, and J. Tol), Erasmus Medical Center, Rotterdam, The Netherlands; and Flanders Interuniversity Institute of Biotechnology (VIB) (Drs. Dermaut, Cruts, Broeckhoven, and Munteanu), Born-Bunge Foundation (BBS), University of Antwerp (UIA), Department of Biochemistry, Antwerpen, Belgium.
Address correspondence and reprint requests to Dr. C.M. van Duijn, Department of Epidemiology & Biostatistics, Erasmus Medical Center, PO Box 1738, Rotterdam, The Netherlands; e-mail: vanduijn{at}epib.fgg.eur.nl
BACKGROUND: Whereas several authors recently reported a positive association between the 
2-macroglobulin gene (A2M) and late-onset AD (LOAD), others were unable to replicate these findings. Early-onset AD (EOAD) is defined as onset age <65 years. Virtually all patients with LOAD are >65 years of age.
OBJECTIVE: To evaluate the role of A2M in AD, the authors conducted a population-based study of EOAD and LOAD as well as a meta-analysis of all studies conducted to date.
METHODS: Patients with EOAD (n = 100) were derived from a population-based study in four northern provinces of the Netherlands and the area of metropolitan Rotterdam. Patients with LOAD (n = 344) were drawn from the Rotterdam Study, a population-based prospective study on residents aged 55 years and over of a Rotterdam suburb in the Netherlands. Two polymorphisms were studied, A2M-I/D and A2M-Ile1000Val, in relation to the APOE 
4 allele (APOE*4).
RESULTS: No genotypic or allelic association was found for either polymorphism in the population-based series of patients with LOAD. In patients with EOAD without APOE*4, a significant increase of carriers of A2M-1000Val was found. The meta-analysis of available published case–control data on these polymorphisms in white and mixed ethnic populations yielded no significant differences between cases and controls. Pooling the Asian studies conducted to date showed a significant decrease in the frequency of A2M-D among patients.
CONCLUSIONS: These results suggest that A2M is not genetically associated with LOAD in white patients or mixed populations as found in the United States. In these populations A2M does not have clinical relevance. From a scientific perspective, the findings on EOAD and Asian patients require replication and further research in the A2M region.
This article has been cited by other articles:
|
|
 |
|
  A. D'Introno, V. Solfrizzi, A. M. Colacicco, C. Capurso, F. Torres, S. A. Capurso, A. Capurso, and F. Panza Polymorphisms in the Oxidized Low-Density Lipoprotein Receptor-1 Gene and Risk of Alzheimer's Disease J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2005; 60(3): 280 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sleegers, G. Roks, J. Theuns, Y. S. Aulchenko, R. Rademakers, M. Cruts, W. A. van Gool, C. Van Broeckhoven, P. Heutink, B. A. Oostra, et al. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population Brain, July 1, 2004; 127(7): 1641 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ntais, A. Polycarpou, and J. P. A. Ioannidis Meta-Analysis of the Association of the Cathepsin D Ala224Val Gene Polymorphism with the Risk of Alzheimer's Disease: A HuGE Gene-Disease Association Review Am. J. Epidemiol., March 15, 2004; 159(6): 527 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zappia, I. Manna, P. Serra, R. Cittadella, V. Andreoli, A. La Russa, F. Annesi, P. Spadafora, N. Romeo, G. Nicoletti, et al. Increased Risk for Alzheimer Disease With the Interaction of MPO and A2M Polymorphisms Arch Neurol, March 1, 2004; 61(3): 341 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Saunders, L. Bertram, K. Mullin, A. J. Sampson, K. Latifzai, S. Basu, J. Jones, D. Kinney, L. MacKenzie-Ingano, S. Yu, et al. Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin Hum. Mol. Genet., November 1, 2003; 12(21): 2765 - 2776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J-C Lambert, E Luedecking-Zimmer, S Merrot, A Hayes, U Thaker, P Desai, A Houzet, X Hermant, D Cottel, A Pritchard, et al. Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease J. Med. Genet., June 1, 2003; 40(6): 424 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Blacker, L. Bertram, A. J. Saunders, T. J. Moscarillo, M. S. Albert, H. Wiener, R. T. Perry, J. S. Collins, L. E. Harrell, R. C.P. Go, et al. Results of a high-resolution genome screen of 437 Alzheimer's Disease families Hum. Mol. Genet., January 1, 2003; 12(1): 23 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Neugroschl and K. L. Davis Biological Markers in Alzheimer Disease Am J Geriatr Psychiatry, December 1, 2002; 10(6): 660 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zappia, R. Cittadella, I. Manna, G. Nicoletti, V. Andreoli, S. Bonavita, A. Gambardella, and A. Quattrone Genetic association of {alpha}2-macroglobulin polymorphisms with AD in southern Italy Neurology, September 10, 2002; 59(5): 756 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Mettenburg, D. J. Webb, and S. L. Gonias Distinct Binding Sites in the Structure of alpha 2-Macroglobulin Mediate the Interaction with beta -Amyloid Peptide and Growth Factors J. Biol. Chem., April 5, 2002; 277(15): 13338 - 13345. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
